Contineum Therapeutics
(NASDAQ) CTNM
Contineum Therapeutics Financials at a Glance
Market Cap
$473.22M
Revenue (TTM)
$0.00
Net Income (TTM)
$59.98M
EPS (TTM)
$-2.18
P/E Ratio
-5.59
Dividend
$0.00
Beta (Volatility)
0.52 (Low)
Dividend
$0.00
Beta (Volatility)
0.52 (Low)
Price
$12.20
Volume
19,821
Open
$12.26
Price
$12.20
Volume
19,821
Open
$12.26
Previous Close
$12.20
Daily Range
$12.18 - $12.94
52-Week Range
$3.35 - $16.33
Dividend
$0.00
Beta (Volatility)
0.52 (Low)
Price
$12.20
Volume
19,821
Open
$12.26
Previous Close
$12.20
Daily Range
$12.18 - $12.94
52-Week Range
$3.35 - $16.33
CTNM News
CTNM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Contineum Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
51
CEO
Carmine N. Stengone, MBA
Website
www.contineum-tx.comHeadquarters
San Diego, CA 92121, US
CTNM Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-26%
Return on Capital
-26%
Return on Assets
-22%
Earnings Yield
-17.89%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$473.22M
Shares Outstanding
38.76M
Volume
19.82K
Short Interest
0.00%
Avg. Volume
266.54K
Financials (TTM)
Gross Profit
$323.00K
Operating Income
$68.06M
EBITDA
$68.06M
Operating Cash Flow
$55.31M
Capital Expenditure
$231.00K
Free Cash Flow
$55.54M
Cash & ST Invst.
$262.90M
Total Debt
$8.25M
Contineum Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$85.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$473.22M
N/A
Market Cap/Employee
$11.54M
N/A
Employees
41
N/A
Net Income
$15.16M
-4.1%
EBITDA
$17.03M
-17.5%
Quarterly Fundamentals
Net Cash
$254.65M
+28.3%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$5.91M
+22.9%
Short Term Debt
$2.34M
+61.2%
Return on Assets
-21.68%
N/A
Return on Invested Capital
-25.50%
N/A
Free Cash Flow
$13.08M
-26.2%
Operating Cash Flow
$13.04M
-27.8%